{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:21:07Z","timestamp":1792441267668,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.pnpbp.2011.06.011","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T14:24:18Z","timestamp":1309789458000},"page":"1808-1809","source":"Crossref","is-referenced-by-count":7,"title":["Venlafaxine in somatopsychic and autopsychic depersonalization"],"prefix":"10.1016","volume":"35","author":[{"given":"Matteo","family":"Preve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.06.011_bb0055","series-title":"Diagnostic and statistical manual of mental disorders, (4th ed-Text revision)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.pnpbp.2011.06.011_bb0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00005053-199712000-00006","article-title":"Dissociative symptoms in panic disorder","volume":"185","author":"Ball","year":"1997","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.06.011_bb0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00406-008-0849-0","article-title":"The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis","volume":"259","author":"Bauer","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.06.011_bb0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.neuropsych.22.3.352-j.e16","article-title":"Alice in the wonderland syndrome in major depressive disorder","volume":"22","author":"Bui","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2011.06.011_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-440X(89)90112-0","article-title":"Derealization and panic attacks: a clinical evaluation on 150 patients with panic disorder\/agoraphobia","volume":"30","author":"Cassano","year":"1980","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.011_bb0025","first-page":"3","article-title":"Pharmacological dissection of panic and depersonalization","volume":"146","author":"Hollander","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.011_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00127-004-0701-4","article-title":"The epidemiology of depersonalization and derealization. A systematic review","volume":"39","author":"Hunter","year":"2004","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.06.011_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1092852900018721","article-title":"Venlafaxine treatment of obsessive-compulsive disorder: case reports","volume":"8","author":"Marazziti","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pnpbp.2011.06.011_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00005053-200105000-00013","article-title":"Is panic disorder with psychosensorial symptoms (depersonalization-derealization) a more severe clinical subtype?","volume":"189","author":"Marquez","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.pnpbp.2011.06.011_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2006.08.025","article-title":"The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal","volume":"99","author":"Mula","year":"2007","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.06.011_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/14737175.8.1.19","article-title":"Depersonalization disorder: pharmacological approaches","volume":"8","author":"Sierra","year":"2008","journal-title":"Expert Rev Neurother"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T18:53:43Z","timestamp":1543690423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611002016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0278584611002016"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.06.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}